bringing evidence-based medicine to consumers alliance for health reform january 12, 2005 gail...
TRANSCRIPT
Bringing Evidence-Based Medicine to Consumers
Alliance for Health Reform
January 12, 2005
Gail Shearer
Director, Health Policy Analysis
Washington Office
Consumers Union
“Consumer Driven” Health Care?• Is it defined contribution health care in reality?• Adverse segmentation of the health insurance
marketplace• Evidence-based medicine should be foundation
for universal coverage, comprehensive drug benefits, and improvements in the marketplace as it saves money and rationalizes delivery of care
Section 1013: Medicare Modernization Act• Bipartisan effort• Appeals to those who want to provide financial
relief• Appeals to those who want to curb federal
spending and deficit• AHRQ priorities: constructive first step• Section 1013 calls for findings that are “easily
understood” by the public and available both online and in print
MISSION:
• Information on prescription drugs for consumers and doctors
• Increase access to and affordability of needed medicines
• Relieve financial burden caused by high drug prices – consumers and businesses
METHODS: (1) Drug Effectiveness Review Project
• Pioneering work under leadership of former Oregon Governor John Kitzhaber
• Partnership (DERP) now includes 12 states and two non-profit organizations
• Systematic reviews by AHRQ’s Evidence-Based Practice Centers
• Process: transparent, unbiased, rigorous, highly regarded
METHODS: (2) Medical Input and Prices
• Input from medical consultant• Data on average national retail price paid by
cash-paying consumer• CU team reviews effectiveness and cost• Input from CU’s medical advisor, health editorial
team, statistician, 2-3 outside medical peer reviewers for each category
METHODS: (3) Identifying CR Best Buy Drugs
CU team reviews the effectiveness and cost data, and selects one or more drugs that:
• Are in the top tier of effectiveness• Have a safety record as good as others in the
category• Have an average price substantially lower than
the most costly drug in the category
CR BEST BUY DRUGS: Cholesterol–Lowering Drugs/Statins
For moderate cholesterol reduction:
• Generic lovastatin
Substantial cholesterol reduction:
• Atorvastatin (Lipitor)
POSSIBLE ANNUAL SAVINGS: 3 Categories
• Statins $1,300 (cholesterol)
• Proton Pump Inhibitors: $1,740 (acid reflux and ulcers)
• NSAIDs $2,200 (arthritis and pain)
Just the beginning …
• Continue to draw on DERP reports
• One per month
• Next up: anti-depressants (SSRIs), high blood pressure and heart disease (ACE Inhibitors and Beta Blockers)